The expression of PSCA in breast cancer seems to be related to clinicopathological features so that the expression of this protein is associated with undesirable histopathological grade and increased proliferation activity and has no association with age, histological subtype, tumor stage, nodal status, lymphatic-invasion or angio-invasion and survival of patients [54]. The gene discussed is PSCA; the disease is breast carcinoma.